Thursday, 18 July 2019

Drug Discovery News

  • TSRI, Takeda expand research collaboration

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2013

    Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collaboration to search for new drug targets for a variety of diseases. The...Read more

  • Prima recruits patients for cancer vaccine trial

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more

  • Merck pays Bionomics $172mn for pain molecules

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and Canada, to discover and develop novel small molecule candidates for ...Read more

  • Bayer initiates trial of new rFVIII to treat hemophilia A

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that is designed to evaluate its investigational compound BAY94-9027 for th...Read more

  • Eli Lilly, China firm to co-develop diabetes drug

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jul, 2014

    ‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop Lilly's glucokinase activator (GKA), LY2608204, that has completed Pha...Read more

  • ScinoPharm, Coland develop cancer generics in China

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 May, 2013

    ‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to develop a series of generic oncological drugs for China. Several Acti...Read more

  • VM202 trial completes patient administration

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients for the company's ongoing phase II clinical trial of VM202-DPN in US/K...Read more

  • Researchers find gene mutation to lower heart disease

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital, have discovered four rare gene mutations that lower the levels of tr...Read more

  • EMA to review marketing plea for antipsychotic medication

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an atypical antipsychotic medication lurasidone hydrochloride. The product ...Read more

  • Chipscreen gets SFDA nod after accelerated review

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    ‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, registrational phase II Chipel trial of Chidamide (Epidaza), an orally...Read more

  • FDA affirms superiority of Pradaxa over warfarin

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2012

    Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischemic and hemorrhagic strokes relative to warfarin. This positive change...Read more

  • Sanofi withdraws diabetes drug NDA in the US

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide in the US and plans to resubmit in 2015.Lixisenatide is approved in Eu...Read more

  • Amgen to acquire Onyx for $10 bn cash

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals for $125-per-share, totalling to $10.40 billion, in cash. The deal woul...Read more

  • Effient trial by Daiichi, Lilly fails to meet primary endpoint

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in patients with unstable angina (UA) or non-ST elevation myocardial infarct...Read more

  • Astellas Pharma opens office in Singapore

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2013

    Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million as at March 31, 2013, has opened its office in Singapore. Astellas w...Read more

  • A*STAR, GSK develop medicines for emerging markets

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Apr, 2013

    Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-year strategic agreement to develop new evidence based formulations (E...Read more

  • Aussie firm gets TGA approval for pancreatic cancer drug

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Goods Administration (TGA) approval for ABRAXANE (nanoparticle albumin-bo...Read more

  • Pharmaxis gets grants for fibrotic research

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University of Sydney have been awarded funding under the Australian Research Coun...Read more



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls